USPTO serial 79143569
MONTAVIT
Reviewed by CopyMark Law Group
Reg. 4639073Status 404
- Filing date
- Status date
- Registration date
- Nov 18, 2014
- Examiner
- SINGH, TEJBIR
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MONTAVIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
A-6060 ABSAM, AT
Other trademarks owned by PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
A-6060 ABSAM, AT
Other trademarks owned by PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
A-6060 ABSAM, AT
Other trademarks owned by PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebeccah Gan
Rebeccah Gan WENDEROTH LLP1030 15th Street, NW Suite 400 EastWashington, D.C., DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Allergy medications; Antiallergic medicines; Medicines for intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations acting on the central nervous system; Pharmaceuticals, namely, antihelmintics and antihistamines; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for treating alimentary tract and canal diseases and illnesses; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; All-purpose disinfectants; Urinary tract disinfectants; Disinfectants for sanitary purposes; Dietetic foodstuffs in the nature of vitamin supplements, vitamins and vitamin preparations, mineral food supplements, mineral supplements, mineral nutritional supplements, vitamin and mineral preparations for medical use, dietary and nutritional supplements and nutraceuticals for use as a dietary supplement; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babies | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
- Other trademarks owned by PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
- Other trademarks owned by PHARMAZEUTISCHE FABRIK MONTAVIT GESELLSCHAFT M.B.H.
- Other trademarks in Class 005
- Similar marks named MONTAVIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 2, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 2, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 11, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 8, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 8, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 25, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 4, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 4, 2021 | C71T | CANCELLED SECTION 71 | — |
| Nov 18, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 4, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 16, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 16, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 18, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 18, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 29, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 13, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 13, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 13, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 31, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 30, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 30, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 30, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 30, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 29, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 29, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 23, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jul 18, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 8, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 23, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 23, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 23, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 22, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 12, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 8, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 7, 2014 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 6, 2014 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |